Miris Holding
37.50 SEK
Less than 1K followers
MIR
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.42 %
-3.83 %
+22.93 %
+18.82 %
-20.04 %
+24.31 %
-81.16 %
-96.86 %
-99.93 %
Miris is a biotechnology company that develops analytical instruments and consumables for human breast milk and fluids. The company has a particular focus on analyzing milk to provide proper nutrition to premature infants. The products are sold under separate brands and include a complete set of services and consumables. Miris operates on a global level, with headquarters based in Uppsala.
Read moreMarket cap
49.97M SEK
Turnover
-
Revenue
17.47M
EBIT %
-22.84 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
28/5
2026
General meeting '26
28/5
2026
Interim report Q1'26
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Miris Holding, Investor Day, Stockholm Corporate Finance Life Science Seminarium 2026
Stockholm Corporate Finance 17:e Kapitalmarknadsdagar — Life Science 2026 │ 18:e mars
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools